BRADFORD CARPER: Open Payments
NPI 1770587057 · WARRENSBURG, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 40 payments from 18 companies in 2025. Trend: 2023 $1,617 · 2024 $1,263 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Novo Nordisk Inc | 4 | $66 |
| Amgen Inc. | 4 | $65 |
| PFIZER INC. | 3 | $49 |
| ABBVIE INC. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $37 |
| Viatris Specialty LLC | 2 | $33 |
Products named: REXULTI, MOUNJARO, AIRSUPRA, Wegovy, OTEZLA, GEMTESA, Dexcom G6 Transmitter, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
